Advances in the Drugs Treatment of Psoriatic Arthritis by LU Chaofan, LENG Xiaomei

Subjects: “…conventional synthetic disease-modifying antirheumatic drugs…”
Get full text

Targeted Therapy for Rheumatoid Arthritis in the New Era by WANG Jun, MENG Juan

Subjects: “…biologic disease-modifying antirheumatic drugs…”
Get full text

Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An extension study by Małgorzata Wisłowska

Subjects: “…biological disease modifying antirheumatic drugs (bdmards)…”
Get full text

Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India by Keerthi Talari, Vinod Ravindran, Pradip Kumar, Pravin Patil, Sarath Chandra Mouli, Syamasis Bandyopadhyay, Balebail G Dharmanand, Abhrajit Ray, Shankaralingam Rajeshwari, Sanjiv N Amin, Jyotsna Oak, Ved Chaturvedi, Anand N Malaviya, Sukumar Mukherjee

Subjects: Get full text

Efficacy and safety of conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis-interstitial lung disease: A narrative... by Richard Conway, Luke Corcoran, Elena Nikiphorou

Subjects: “…biologic disease-modifying antirheumatic drugs…”
Get full text

Real life experience of a screening strategy for latent tuberculosis before treatment with biologicals in indian patients with rheumatic diseases by Anand N Malaviya, Ravita Thakaran, Roopa Rawat, Sanjiv Kapoor, Shriram Garg, Sadhana S Baghel, Christy Messi, Vivekanand, Qamar Zaheer

Subjects: “…Biological disease-modifying antirheumatic drugs…”
Get full text

Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis by Abhishek Zanwar, Sakir Ahmed, Durga Prasanna Misra, Vikas Agarwal, Aman Sharma, Anupam Wakhlu, Vir Singh Negi

Subjects: “…Biologic disease-modifying antirheumatic drug…”
Get full text

Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis by Peter Youssef, Sabina Ciciriello, Talib Tahir, Joanna Leadbetter, Belinda Butcher, Miriam Calao, Nicole Walsh, Catherine O’Sullivan, Tegan Smith, Geoffrey Littlejohn

Subjects: “…Biologic disease-modifying antirheumatic drug (bDMARD)…”
Get full text